FDA Adverse Event Injury Summary report: N

CREATININE PLUS SYSTEM PACK

MDR report key: 118827 · Received September 8, 1997

Report

Report Number
1823260-1997-00075
Event Type
Injury
Date Received
September 8, 1997
Date of Event
July 26, 1997
Report Date
July 26, 1997
Manufacturer
BOEHRINGER MANNHEIM CORP.
Product Code
CGL
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

CANCER PATIENT WITH UNSPECIFIED "ILLNESS" WAS HOSPITALIZED BASED ON A CREATININE RESULT OF 13.8 MG/DL FROM THE SUSPECT DEVICE. THE FOLLOWING DAY, AN ALTERNATE METHOD (JAFFE REACTION) WAS USED TO ASSAY THE SAMPLE WITH A RESULT OF 2.0 MG/DL. THE TREATING PHYSICIAN BELIEVED THE 2.0 MG/DL VALUE BETTER FIT THE PATIENT'S CONDITION. THE PATIENT WAS TRANSFUSED WITH 2 UNITS OF BLOOD, BUT THE REPORTING TECHNICIAN DID NOT KNOW IF THIS WAS BEFORE OR AFTER THE CREATININE TEST.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CREATININE PLUS SYSTEM PACK CREATININE REAGENT CGL BOEHRINGER MANNHEIM CORP. R1/R2 67848101/67846201

Patients

Seq Age Sex Outcome Treatment
1 86 YR Hospitalization